You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Some of the factors that may have turned Buffett off to JNJ recently.
Our health-care roundtable gathers The Motley Fool's top health-care analysts to discuss the sector's biggest stories in a free flowing and highly opinionated format.
In this portion of the video, the guys speculate on what Johnson & Johnson (JNJ -0.65%) should be doing for shareholders, and why the company's lack of interest in share buybacks now might be a reason Warren Buffett's Berkshire Hathaway (BRK.A -0.18%) walked away.
Brenton Flynn and David Williamson have no positions in the stocks mentioned above. The Motley Fool owns shares of Johnson & Johnson. Motley Fool newsletter services recommend Johnson & Johnson. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
